Verret, Benjamin

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

Nault, J.-C., Datta, S., Imbeaud, S., Franconi, A., Mallet, M., Couchy, G., Letouzé, E., Pilati, C., Verret, B., Blanc, J.-F., et al. (2015) · Nature Genetics

Virus-based gene therapy researchCancer Genomics and Diagnostics

Cited by 489

Efficacy of PI3K inhibitors in advanced breast cancer

Verret, B., Cortes, J., Bachelot, T., Andre, F., & Arnedos, M. (2019) · Annals of Oncology

PI3K/AKT/mTOR signaling in cancerAdvanced Breast Cancer Therapies

Cited by 221

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas

Blanchi, J., Taleb, S., Bayle, A., Verret, B., Toulmonde, M., Spalato‐ceruso, M., Dubos, P., Laizet, Y., Alame, M., Khalifa, E., et al. (2023) · Cancer Communications

Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics

Cited by 12

Efficacy and safety of immune checkpoint blockade in patients with Li-Fraumeni syndrome

Bottosso, M., Verret, B., Caron, O., Hamzaoui, N., Pasmant, E., Danlos, F.-X., Boudou-Rouquette, P., Srikaran, A., Blons, H., Guarneri, V., et al. (2024) · JCO Precision Oncology

Cancer Immunotherapy and BiomarkersImmunodeficiency and Autoimmune Disorders

Cited by 6